30 min listen
2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis
FromThe Hematologist
2021 ASH Annual Meeting: Plenary Abstract on ATLAS-INH in Patients With Hemophilia A or B With Inhibitors, Drs. Guy Young & Laura Michaelis
FromThe Hematologist
ratings:
Length:
13 minutes
Released:
Dec 2, 2021
Format:
Podcast episode
Description
In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract evaluates the efficacy and safety of fitusiran prophylaxis in a multicenter phase 3 study (ATLAS-INH) in patients with hemophilia A or B with inhibitors. For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Dec 2, 2021
Format:
Podcast episode
Titles in the series (100)
Heparin-Induced Thrombocytopenia: A Preventable Nosocomial Disease: In his Diffusion article from the July/August issue of The Hematologist, Dr. Adam Cuker (University of Pennsylvania) covers options to reduce the incidence of heparin-induced thrombocytopenia (HIT), treating it as a preventable nosocomial disease rather t by The Hematologist